Better understanding of the molecular biology of cancer led to newer drugs which are aimed to target specific cell signalling pathways known to cause cancer cellular proliferation, thus leading to cell kill in the selected cell population with abnormal molecular alterations and relatively sparing normal cells.
Several oral and intravenous targeted therapies are available which are routinely used either as a single agent or as a combination with chemotherapy or immunotherapy.